---
id: aasm-narcolepsy-2024
title: "AASM 2024 Clinical Practice Guideline: Treatment of Narcolepsy and Hypersomnolence in Adults"
short_title: "AASM Narcolepsy 2024"

organization: American Academy of Sleep Medicine
collaborators: null
country: US
url: https://aasm.org/clinical-resources/practice-standards/
doi: null
pmid: null
open_access: true

specialty: sleep-medicine
guideline_type: clinical-practice
evidence_system: AASM GRADE
conditions:
  - narcolepsy
  - narcolepsy type 1
  - narcolepsy type 2
  - idiopathic hypersomnia
tags:
  - modafinil
  - sodium oxybate
  - pitolisant
  - solriamfetol
  - cataplexy

publication_date: 2024-03-01
previous_version_date: 2021-01-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-24
---

## Scope
2024 AASM clinical practice guideline update on the pharmacological treatment of narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia in adults.

## Key Recommendations

### Narcolepsy Type 1 (with Cataplexy)

#### Excessive Daytime Sleepiness (EDS)
- **Modafinil/Armodafinil**: First-line for EDS. STRONGLY recommended.
- **Solriamfetol**: Dopamine/norepinephrine reuptake inhibitor. STRONGLY recommended.
- **Pitolisant**: H3 receptor antagonist/inverse agonist. STRONGLY recommended.
- **Sodium Oxybate / Oxybate Salts (Xyrem, Xywav)**: Effective for both EDS and cataplexy. STRONGLY recommended.

#### Cataplexy
- **Sodium Oxybate / Oxybate Salts**: First-line for cataplexy.
- **Pitolisant**: Also effective for cataplexy.
- **Antidepressants (Venlafaxine, SSRIs, TCAs)**: Conditionally recommended for cataplexy suppression (off-label).

### Narcolepsy Type 2 (without Cataplexy)
- **Modafinil, Solriamfetol, Pitolisant**: Recommended for EDS.

### Idiopathic Hypersomnia
- **Modafinil/Armodafinil**: First-line.
- **Sodium Oxybate**: May be considered (FDA-approved for IH).
- **Solriamfetol**: May be considered.

### Stimulants
- Traditional stimulants (amphetamine, methylphenidate) may be used if first-line agents are ineffective or unavailable, though they carry higher abuse potential.

### Behavioral/Lifestyle Measures
- Scheduled naps (10-20 minutes) may provide refreshing relief.
- Good sleep hygiene and consistent sleep schedules.
